Senior BD hires at The Electrospinning Company to drive growth in key areas Executives bring more than 30 years’ experience in global medical device companies
Harwell, UK, September 12th, 2023 – The Electrospinning Company, a leading contract research, development and manufacturing organisation for electrospun biomaterials in medical devices, is driving its international expansion with the appointment of two senior business development executives. Conan Campbell, who joins as Senior Director of Business Development, is a specialist in vascular implant coatings. North America is the focus for Jeff Orosco, also appointed a Senior Director of Business Development. With increased recognition of the potential of electrospinning production for biomaterials such as coatings, membranes and scaffolds, this investment in the team is expected to expand its business considerably.
Conan has spent more than 20 years in the medical device industry, specifically in the vascular space, with companies such as Medtronic, Surgical Specialities and Lake Region Medical. He joins from Integer Holdings. Also highly experienced in medical devices, Jeff has more than 15 years of experience in commercialisation, contract manufacturing operations and business development strategy. He has worked at DSM Biomedical, Zimmer Biomet and Conmed across orthopaedics, sports medicine, tissue and biologics, wound care, cardiology and wearables.
Welcoming the new appointees, CEO Ann Kramer said, ‘Conan and Jeff’s experience and insights are already proving invaluable to the expansion of our business. They are expected to play a significant role in development of our partnerships with existing and new customers across the world, in a range of therapeutic areas and modalities.’
Senior BD Director Conan Campbell said, ‘I’m really excited by the potential of our electrospinning platform technology and look forward to working with medical device innovators developing implants in areas of unmet medical need.’
Senior BD Director (North America) Jeff Orosco added, ‘The potential of electrospun materials in the US medical device industry is considerable and we’ll be focused on increasing our penetration of this complex and important market.’
For more information please contact:
The Electrospinning Company
Ann Kramer, CEO info@electrospinning.co.uk
About The Electrospinning Company
The Electrospinning Company offers contract services to design, develop and manufacture nanofibrous biomaterials for medical devices. Based on the electrospinning platform technology, they use their expertise and experience to support clients in a range of different therapeutic indications, including the supply of the first electrospun biomaterial to be incorporated into an FDA-approved medical device. The company is also using its know-how to develop proprietary materials for targeted out-licensing opportunities. The company is a spin-out from the UK Science and Technology Facilities Council (STFC) and is located on the Harwell Innovation Campus near Oxford, UK. It is backed by strategic investor Confluent Medical as well as Downing LLP, Intuitive Investments Group plc, STFC Innovations Ltd and business angels. Further information can be found on the company’s website https://www.electrospinning.co.uk/
